ASTS
AST SpaceMobile, Inc.
ASTS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
GIB
CGI Inc.
GIB has the edge over ASTS overall, supported by lower modeled downside and stronger fundamentals.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
GIB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Healthy |
GIB's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
GIB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 14x | $81.81 | — |
| Cheap | 17x | $97.00 | +19% |
| Fair | 20x | $114 | +39% |
| Expensive | 22x | $127 | +55% |
Historical ranges are pointers, not guarantees.
GIB's PE is 14x, but its earnings don't support one, so it isn't a reliable read right now.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
GIB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect GIB's earnings to grow and its profitability to improve, with its revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
GIB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $5.67 | +7.2% |
| Q1 2026 | $5.39 | +0.7% |
| Q4 2025 | $5.24 | -1.3% |
| Q3 2025 | $5.16 | +0.4% |
| Q2 2025 | $5.29 | +5% |
| Q1 2025 | $5.35 | +8.5% |
| Q4 2024 | $5.31 | +8.8% |
| Q3 2024 | $5.14 | +6.4% |
GIB has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
GIB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.9B | +2.5% |
| Q1 2026 | $2.9B | +3.3% |
| Q4 2025 | $2.9B | +7.7% |
| Q3 2025 | $2.8B | +9.7% |
| Q2 2025 | $2.9B | +11% |
| Q1 2025 | $2.8B | +7.6% |
| Q4 2024 | $2.7B | +5.1% |
| Q3 2024 | $2.6B | +4.4% |
GIB's revenue has grown year over year for 20 quarters in a row: $2.9B last quarter, up 2.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 16% | 0 points |
| Q1 2026 | 17% | +0.1 points |
| Q4 2025 | 16% | -0.1 points |
| Q3 2025 | 33% | +17 points |
| Q2 2025 | 16% | -0.1 points |
| Q1 2025 | 17% | -0.3 points |
| Q4 2024 | 16% | +0.2 points |
| Q3 2024 | 16% | +16 points |
GIB has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
GIB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $374.2M | +30% |
| Q1 2026 | $295.6M | +15% |
| Q4 2025 | $568.2M | +38% |
| Q3 2025 | $423M | +5.1% |
| Q2 2025 | $288.9M | -4.1% |
| Q1 2025 | $257.5M | -14% |
| Q4 2024 | $411.6M | +14% |
| Q3 2024 | $402.6M | +4.8% |
GIB has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GIB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | 0.7x | Very low |
GIB's net debt is about 1.2 years of its operating earnings (EBITDA), up from 1.1 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
GIB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.0 | Neutral |
| Stochastic | 91.1 | Overbought |
GIB's weekly RSI is 61 (neutral) and its Stochastic is 91 (overbought).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
GIB PE vs Technology Sector
| Metric | GIB | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 48% below |
| PE % | 11 | 35 | 24 pts below |
GIB is trading at 14x earnings, a 48% discount to the Technology sector's median of 28x, though its earnings don't support one.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
GIB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $76.4 | 7.1% above |
| 20 week MA | $73.2 | 12% above |
| 50 week MA | $75.4 | 8.6% above |
| 100 week MA | $88.2 | 7.2% below |
| 200 week MA | $96.2 | 15% below |
GIB has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
GIB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $84.1 | $79.4 | -5.6% |
| 2021 | $79.4 | $87.3 | +10% |
| 2022 | $87.3 | $85.9 | -1.5% |
| 2023 | $85.9 | $107.2 | +25% |
| 2024 | $107.2 | $109.9 | +2.5% |
| 2025 | $109.9 | $93.8 | -15% |
| 2026 YTD | $93.8 | $81.8 | -13% |
GIB has the edge over ASTS on returns for 2026, with the stronger performance.